20 clinical trials found.
-
Longitudinal Cohort of Older Individuals with Crohn s and Colitis: Differentiating the Fit from the Frail
Frailty is an age-related decline in multiple physiologic systems that confers significant vulnerability to health related changes.Frailty has been demonstrated to be a predictor ...Phase N/A
TRIAL ROLE: Principal Investigator
-
Sarcopenia as a Risk Factor for Adverse Postoperative Outcomes in IBD
We will conduct a prospective cohort study of 120 patients at NYU Langone. Patients who have a biopsy confirmed diagnosis of IBD, who are = 18 ...Phase N/A TRIAL ROLE: Principal Investigator
-
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
IBD Plexus is a research and information exchange platform whose goal is to accelerate research and transform the care of patients with IBD. IBD Plexus ...Phase N/A TRIAL ROLE: Sub Investigator
-
RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 2 STUDY OF VE202 IN PATIENTS WITH MILD-TO-MODERATE ULCERATIVE COLITIS
VE202 is a rationally designed, live biotherapeutic product (LBP) for oral (po) administration that consists of 16 well-characterized, clonally-derived, nonpathogenic, nontoxigenic, commensal strains of Clostridia ...Phase
TRIAL ROLE: Sub Investigator
-
A Phase 3 Randomized Double-Blind Placebo-Controlled Program to Evaluate the Efficacy and Safety of MK-7240 in Participants with Moderately to Severely Active Ulcerative Colitis
This trial is testing MK-7240 in people with moderate to severely active ulcerative colitis (UC). This trial will compare MK-7240 to placebo. A placebo looks ...Phase
TRIAL ROLE: Sub Investigator
-
A Phase 3 Randomized Double-Blind Placebo-Controlled Program to Evaluate the Efficacy and Safety of Tulisokibart in Participants with Moderately to Severely Active Crohn s Disease
This trial is testing an experimental drug tulisokibart (MK-7240) in people with moderately to severely active Crohn’s disease (CD). This trial will compare tulisokibart ...Phase
TRIAL ROLE: Sub Investigator
-
A Multicenter Randomized Double-blind 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)
The purpose of this study is to learn more about the study drug, GS-1427. This will include:- Testing if 3 different doses of GS-1427 work ...
Phase
TRIAL ROLE: Sub Investigator
-
Prospective Cohort Registry of Patients with Inflammatory Bowel Disease and Overlap Spondyloarthritis
The purpose of this research study is to use two questionnaires to identify patients who have both inflammatory bowel disease and spondyloarthritis and to then ...Phase N/A TRIAL ROLE: Sub Investigator
-
A Phase 4 Prospective Open label Study of Ozanimod to Explore the Safety Efficacy Quality of Life and Biomarker Response in Participants with Moderate to Severe Ulcerative Colitis in Clinical Practice
Ulcerative colitis (UC) is a chronic inflammatory disorder affecting the gastrointestinal tract. Patients with UC experience symptoms such as diarrhea, rectal bleeding, weight loss, abdominal ...Phase
TRIAL ROLE: Sub Investigator
-
A Phase 1b/2 Study to Demonstrate the Safety and Efficacy of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an Ileal Pouch-Anal Anastomosis
The aim of this study is to assess the safety and preliminary efficacy of treatment with EXE-346, a live biotherapeutic product (LBP)containing a fixed ...Phase
TRIAL ROLE: Sub Investigator
